Final AMiCI Conference placed in Kraków on February 18-20 is already history. The main target of the conference was to summarize the AMiCI action with the view to formulate the official statement of antimicrobial coatings addressed to EU.
Final days that took place in Jagiellonian University, Faculty of Chemistry brought the expected results. The program and selected presentations are presented in order of appearance.
AMiCI – the COST Action
The AMiCI Story – From project idea to the COST Action. Senior Policy Officer in Science, Dr. Francy Crijns (VieCuri Medical Center, Netherlands) and Dr. Paul Borm (Borm Nanoconsult Holding BV The Netherlands)
Current status of AMiCI Dr Minna Keinänen-Toivola (Satakunta University of Applied Sciences, Finland).
Achievements of working groups and ways forward: WG1 Safe-by-Design
Nuno Azevedo (University of Porto, Portugal) and Simone Schulte (Evonik, Germany)
Achievements of working groups and ways forward WG2 – Performance Assessment, Peter D Askew (Industrial Microbiological Services Ltd, UK) Patrick Cosemans (Sirris, Belgium).
Achievements of working groups and ways forward: WG3: Adverse effects/Risk-Benefit analysis, Anne Kahru, Research Professor National Institute of Chemical Physics and Biophysics, Estonia, WG3 leader. Merja Ahonen, Senior researcher, FT Satakunta University of Applied Sciences, Finland, WG3 co-leader.
US perspectives on antimicrobial coatings Professor, director Matthew Fields (Center for Biofilm Engineering, Montana, USA).
Achievements of working groups and ways forward WG 4 – New Cleaning Methods, Martina Modic (Jožef Stefan Institute, Slovenia) and Colum Dunne (University of Limerick, Ireland).
Achievements of working groups and ways forward WG 5 Communication, Kazimierz Murzyn (Foundation Klaster LifeScience Krakow, Poland).
Overview of STSM – Short term scientific missions
prof. Isabel Gouveia (University of Beira Portugal)
Capacity building of ECIs Training schools, workshop & ITC conference grants, vice-chair of the action Martijn Riool (Amsterdam UMC, the Netherlands) and Dr. Martina Modic (Jožef Stefan Institute, Slovenia).
Legislation and regulations Managing Director Peter Askew (Industrial Microbiological Services Ltd, UK).
Antimicrobial Coatings: From innovation to the market
Dr. Simone Schulte (Evonik, Germany).
Value of COST AMiCI to an ECI. Merilin Rosenberg (National Institute of Chemical Physics and Biophysics, Estonia).
An economic evaluation of antimicrobial coatings in hospital environments
Prof. Colum Dunne (University of Limerick, Ireland).
Formulation of the official statement of antimicrobial coatings to EU
Colum Dunne (University of Limerick, Ireland).
Research and good practices on antimicrobial coatings in different COST AMiCI countries
Nano-Structured Materials for the Development of Individual and Collective Protection Devices to Prevent Biological Risk in Hospitals (NANO-DISP)
Mariamelia Stanzione (National Research Council, Italy).
Polyelectrolytes as antimicrobial coatings Dr. Klemen Bohinc (University of Ljubljana, Slovenia).
Conjugates of Metal Ions with Drugs (NSAID, Antibiotics) (CoMeD’s) or natural bioactive compounds towards the discovery and development of new, effective disinfectant materials, Prof. Sotiris K. Hadjikakou (University of Ioannina, Greece).
Antibacterial nanocomposite coatings: Killing bacteria with nanoheaters, enzymes or natural oils. Dr. Hayriye Unal (Sabancı University Nanotechnology Research and Application Center, Turkey).
Synthesis and characterization of new generation Zn2SnO4–rGO–Mn photo catalyst composite structures for antibacterial applications, Özlem Altintas Yildirim (Turkey)
